The DOI matches its Crossref record; 346 of the 347 references it cites were found in a registry or an index.
Specificity, versatility, and control of TGF-β family signaling
Open accessAbstract
Molecular function and pathway cross-talk in TGF-β signaling reveal its complexity and open questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“they need to effectively interfere with the very high binding affinity (10−11 M range) of TGF-β to cell surface receptor complexes65.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [65]
In the citing paper
“By design, these chimeras, based on the TβRII ligand trap, should sequester TGF-β1 and -β3 only, similarly to dimerized TβRII receptor65.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145 · cited 1×
“On the basis of sequence characteristics, the type I and type II receptors are predicted dual-specificity kinases, able to phosphorylate on serine and threonine, as well as tyrosine, and are phylogenetically clustered proximal to other dual-specificity kinases such asMEK kinases (65, 66).”
BackgroundMolecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Self-citationmTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,239
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
Smad transcription factorsPreprint
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,519
Swatek, K. N., & Komander, D. (2016) · Cell Research · doi:10.1038/cr.2016.39 · Cited by 2,141
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.035 · Cited by 2,112 · cited 1×
“12, eaav5183 (2019) 26 February 2019 rylates and thus activates mTOR, which, among other responses, promotes protein synthesis and cell metabolism, is required for cell migration, and phosphorylates AKT in a positive feedback loop (311, 312).”
BackgroundSPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Self-citation
Flagged first, then by citations
1 of the 347 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- R. Derynck K. Miyazono The Biology of the TGF-β Family (Cold Spring Harbor Laboratory Press 2017) pp. 1164.
Cited by
Sorted by citations
Items 701–797 of 797
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992925
Secchi, C., Benaglio, P., Mulas, F., Belli, M., Stupack, D., & Shimasaki, S. (2021) · Figshare · doi:10.6084/m9.figshare.14131182
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992919
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992904
Tarrass, M. A., Belmudes, L., Koça, D., Azemard, V., Liu, H., Tabosh, T. A., Ciais, D., Desroches‐Castan, A., Battail, C., Couté, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25341247
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14993058
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14993064
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14993052
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992910
Wu, X., Shen, Q., Zhang, Z., Zhang, D., Gu, Y., & Xing, D. (2021) · Figshare · doi:10.6084/m9.figshare.14773927
Zhang, Y., Li, Q.-S., Liu, H.-L., Tang, H.-T., Yang, H.-L., Wu, D., Huang, Y.-Y., Li, L.-C., Liu, L.-H., & Li, M. (2023) · Figshare · doi:10.6084/m9.figshare.24030993
Alishah, K., Birtel, M., Masoumi, E., Jafarzadeh, L., Mirzaee, H. R., Hadjati, J., Voss, R.-H., Diken, M., & Asad, S. (2021) · Figshare · doi:10.6084/m9.figshare.17087824
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14993061
Pucci, M., Moschetti, M., Urzì, O., Loria, M., Conigliaro, A., Bella, M. A. D., Crescitelli, R., Bagge, R. O., Gallo, A., Santos, M. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26583204
Pucci, M., Moschetti, M., Urzì, O., Loria, M., Conigliaro, A., Bella, M. A. D., Crescitelli, R., Bagge, R. O., Gallo, A., Santos, M. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26583201
Pucci, M., Moschetti, M., Urzì, O., Loria, M., Conigliaro, A., Bella, M. A. D., Crescitelli, R., Bagge, R. O., Gallo, A., Santos, M. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26583192
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992901
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14993067
Zhang, Y., Li, Q.-S., Liu, H.-L., Tang, H.-T., Yang, H.-L., Wu, D., Huang, Y.-Y., Li, L.-C., Liu, L.-H., & Li, M. (2023) · Figshare · doi:10.6084/m9.figshare.24030984
Alishah, K., Birtel, M., Masoumi, E., Jafarzadeh, L., Mirzaee, H. R., Hadjati, J., Voss, R.-H., Diken, M., & Asad, S. (2021) · Figshare · doi:10.6084/m9.figshare.17087821
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992886
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14993055
Hou, J., Wang, X., Su, C., Ma, W., Zheng, X., Ge, X., & 段相国 (2022) · Figshare · doi:10.6084/m9.figshare.20222564
Chijimatsu, R., Miwa, S., Okamura, G., Miyahara, J., Tachibana, N., Ishikura, H., Higuchi, J., Maenohara, Y., Tsuji, S., Sameshima, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992889
Research on rhubarb's natural components and their potential for treating chronic kidney disease
Chen, M., Yao, J., & Liu, Z. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103321
Single-cell profiling reveals systemic immune reprogramming in muscle-invasive urothelial carcinomaPreprint
Cha, J., Yang, Y., Yang, J., Guo, J., Xie, H., Li, X., Wang, Y., Wang, J. H., & Lin, C. (2026) · Research Square · doi:10.21203/rs.3.rs-8525731/v1
Research Progress on Radiation-Induced Oral Mucositis and Its Pathogenic Mechanism
张, 思. (2026) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2026.161020
Liu, Q., Wang, R., Li, Z., Liu, Y., Wu, L., & Yang, J. (2026) · South African Journal of Botany · doi:10.1016/j.sajb.2026.01.016
Chen, Z.-Y., Yasen, M., Jiang, S.-Y., Ye, Z., Yang, Q.-X., Lu, C.-N., Shi, Y., Liu, X.-Y., Du, T., Tang, X.-M., et al. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05487-0
Myocardial Matrix Metalloproteinase 3 Protein Expression in Ischemic Heart Failure
Siratavičiūtė, V., Pangonytė, D., Lesauskaitė, V., Utkienė, L., Jusienė, L., Marcinkevičienė, J. E., Kuprytė, M., Gečys, D., Patamsytė, V., Stanionienė, Z., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041697
“MMP3 has been shown to activate latent TGF-β bound to the extracellular matrix by proteolytically removing its latency-associated peptide [6,40,41].”
Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis
Pan, Z., Zerehpoosh, S., Wang, S.-C., Örmecİ, N., Kim, W., & Eslam, M. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s566319
Ye, Z., Wei, X., Miao, Z., He, R., Guan, Y., Wei, Y., Ye, H., Wu, M., Cai, L., & Yu, C. (2026) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2026.02.005
The influence of acute and chronic inflammations on tumor growth
Kaźmierczak, B., & Volpert, V. A. (2026) · Discrete and Continuous Dynamical Systems - B · doi:10.3934/dcdsb.2026046
The Impact of Cysteine Substitutions on TGF-β3 Expression, Purification, Folding, and Activity
Albawaana, A. S., Day, A., & Lu, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052422
“As is well-established, TGF-β superfamily members primarily exert their biological functions in their dimeric forms [25,26].”
Xue, J., Li, T., Xu, Q., Guo, Y., & Wang, H. (2026) · Research Square · doi:10.21203/rs.3.rs-8637051/v1
Modulation of TGF-Β Signaling to Enhance Irinotecan Cytotoxicity in Colorectal Cancer
Ay, E. N., Sarıman, M., & Acar, M. (2026) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1622831
“Transforming growth factor-β (TGF-β) regulates cell differentiation, proliferation, and apoptosis via TGF-β receptors I, II and III (15).”
Cunningham, K. T., Ciancia, C., Campion, T., van Dinther, M., Davis, N., Duffy, A., Heawood, A. L. L., Power, L., Sanders, A., Singh, S. P., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202503194r
Effet du TGFβ produit par le microenvironnement sur les tumeurs du pancréas exocrine
Cardot‐Ruffino, V. (2019) · theses.fr (ABES) · doi:10.70675/5a044019zf697z4071z9643zee4c85ba364f
Le rôle de GDF11 dans les leucémies aiguës myéloïdes
Siavellis, J. (2021) · theses.fr (ABES) · doi:10.70675/b953e730zc0bez4347za9e4z561daebbcc2d
Incidences de l’ischémie cérébrale sur la fonction et la sensibilité cardiaques à l’ischémie
Méloux, A. (2019) · theses.fr (ABES) · doi:10.70675/a9b30413z16cbz4038za961z28b244223160
Bertrand‐Chapel, A. (2021) · theses.fr (ABES) · doi:10.70675/6f1078b7z94d3z4096z85a9z40b435cd6a59
Recazens, E. (2021) · theses.fr (ABES) · doi:10.70675/5b66fe82zcbbbz4251z98c0z2bb967f598c2
Zhou, L., Li, J., Wang, M., & Geng, Y. (2026) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2026.102070
Epigenetic characterization of cellular pliancy in breast cancer
Benhassoun, R. (2024) · theses.fr (ABES) · doi:10.70675/0b1d39b2za3d7z4b26zb4b0zaafa77d5068a
Tarrass, M. A. (2023) · theses.fr (ABES) · doi:10.70675/aea61e27z0cadz4558za7acz92d960d99b81
Konstantinidis, I. K., Tsokkou, S., Pavlidis, P., Papadopoulou, K., Kavvadas, D., Tseriotis, V., Delis, G. A., Sardeli, C., Kouvelas, D., Siogka, A., et al. (2026) · Nutrients · doi:10.3390/nu18081236
Chen, M., Zhao, R., Chen, X., Xu, L., & Hu, C. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.115006
BRD2 is a transcriptional coactivator of Smad3 in mediating TGF-β tumor suppressive responses
Tian, S., Gu, S., Sun, S., Wang, Z., Zhao, Y., Yuan, B., Liu, X., Zhao, B., Xu, P., Cao, J., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03726-8
“CAGA-luc apparently produced more profound effect on TGF-β -induced expression than SBE-luc (Fig.”
Wei, W., Zhang, W., Wang, M., Liu, Y., Ming, S., Li, M., Cheng, P., Cao, W., Li, J. J., Shi, D., et al. (2026) · Molecular Carcinogenesis · doi:10.1002/mc.70114
Asymmetric crosstalk between the BMP and TGFβ pathways resolves signaling ambiguityPreprint
Auth, J. M., Eizenberg-Magar, I., Erez, O., Zachar, O., Shmueli, M. D., Zigdon, I., Shoham, A., Mindel, V., Berrebi, M. A., Tennenhouse, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.20.719570
Mieno, H., Hashida, M., Yoshii, K., Horikiri, T., Urabe, K., Mori, K., Ueno, M., & Sotozono, C. (2026) · Current Eye Research · doi:10.1080/02713683.2026.2660821
Du, M., Liu, Y., He, Q., Zhang, X., Zhao, Y., Li, B., Bai, D., Bou, G., Bao, T., Wen, X., et al. (2026) · BMC Genomics · doi:10.1186/s12864-026-12868-8
“The host gene TGFBRAP1 was specifically chosen because it is a critical adaptor protein in the TGF-β signaling pathway—a master regulator of cell proliferation, differentiation, and apoptosis [45].”
Meng, Y., Chen, Q., & Lu, H. (2026) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2026.2657461
Toward a probabilistic definition of chromatin accessible regions at the single-cell levelPreprint
Sánchez-Escabias, E., Rico, D., & Reyes, J. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.01.722232
“R-SMAD factors oligomerize with SMAD4 and translocate to the nucleus, where they bind chromatin [34].”
Design, synthesis, and biological evaluation of ALK5 PROTAC degraders for pulmonary fibrosis
Yue, L., Li, Y., Gan, C., Sun, M., Deng, C., Xue, T., Xie, Y., Liu, H., Liu, Z., & Ye, T. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109945
Jiang, M., Zhang, K., Zheng, X., Bo, Z., & Wei, R. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i2.17
Gan, S., Yang, S., Pan, J., & Wang, M. (2026) · Medicine · doi:10.1097/md.0000000000048775
“[30,31] The upregulation of EMT transcription factors, such as Snail 1, drives the transition of cancer cells from a differentiated epithelial state to a stem cell-like state, thereby enhancing their metastatic potential.”
Naringin targets TGF-β1-mediated angiogenesis to enhance the osteogenic effect of induced membrane
Li, S., Cai, Q., Wang, S., Zeng, Z., Yang, D., & Zhou, Q. (2026) · Bone and Joint Research · doi:10.1302/2046-3758.155.bjr-2025-0412.r1
“19 One study has confrmed that the TGF-β / SMAD signalling pathway promotes angiogenesis and vascular remodelling by regulating the proliferation of angiogenesis-related cells, such as vascular smooth muscle cells (VSMCs) and endothelial cells.”
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Fibrosis and Cancer
Amengual, J., Espinosa‐Sotelo, R., Cantos‐Cortes, A., Gonfaus-Ortiz, G., Alay, A., Campuzano, V., Egea, G., Bertrán, E., & Fabregat, I. (2026) · Springer eBooks · doi:10.1007/978-3-032-21135-4_21
Larsson, P. F., Schmidt, A., Mu, Y., Zang, G., Song, J., Gajavilli, V., Tao, J., Rakhimova, O., Ericsson, M., Aripaka, K., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02737-x
Xue, J., Deng, J., Qin, H., Li, Y., Jing, Z., Zhao, Z. Y., & Wang, H. (2026) · Discover Oncology · doi:10.1007/s12672-026-05365-7
“Given that both TGF-β and PDGF promote EMT via ERK-MAPK signaling [65, 74], so dipyridamole may inhibit platelet-mediated EMT by targeting this signaling axis.”
Rare protein-coding variation and the genetic architecture of height in >1.4 million individualsPreprint
Kosmicki, J. A., Ganel, L., Watanabe, K., Joseph, T., Gaynor, S. M., Kessler, M. D., Backman, J., Mbatchou, J. S., Ziyatdinov, A., Blair, D., et al. (2026) · medRxiv · doi:10.64898/2026.06.22.26355163
SHP2 negatively regulates TGF-β signaling by destabilizing the TGF-β type I receptor
Zhao, C., Yakymovych, I., Yakymovych, M., Xing, P., & Heldin, C. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03043-3
Hunting gremlins: GREM1 as a new therapeutic target for multiple diseases including glaucoma
Siderovski, D. P., Myneni, N., Botross, M., Patel, P. D., & Clark, A. F. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100152
TGF-β2 exerts neuroprotective effects via inhibition of astrocyte-mediated inflammatory responses
Li, W., Zhang, Q., Shao, J., Jiang, Q., Jh, G., Shi, R., Xu, F., Lu, Y., Cang, C., Liang, C., et al. (2026) · BMC Neuroscience · doi:10.1186/s12868-026-01025-2
“TGF-β2 is a multifunctional cytokine, playing a pivotal role in the formation and maintenance of neural networks by modulating neural cell proliferation [15], differentiation [16], and migration [17].”
Metabolic Regulation by Adipokines, Hepatokines, and Myokines
Stefan, N., White, M. F., & Häring, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00012-3
E3 Ubiquitin Ligase Mind Bomb 1 is a Novel Negative Regulator of Tumor-Suppressive BMP Signaling
Cottonham, C., Hernandez, G. E., Cheung, T. K., Rose, C. M., Srinivasan, R., Piskol, R., Yao, X., & Siebel, C. W. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0760
“The transforming growth factor-β (TGF-β ) family comprises numerous secreted factors regulating various physiologic functions, from embryonic development to immune modulation (1).”
Fonódi, M., Bécsi, B., Tar, K., & Boratkó, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-64537-1
Mechanisms and Manifestations of Ligand Bias in Signaling: Focus on Receptor Tyrosine Kinases
Schuck, R. J., Roy, T., Bondar, A., Krejčı́, P., & Hristova, K. A. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.6c00023
Wang, X., Zhou, L., Ding, H., Zhang, W., Zhu, Y., Li, B., Wang, H., Yu, R., Wang, J., Zhu, M., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122270
Zha, Y., Jiang, S., Zhao, T., Wei, S., Lyu, J., Hu, W., Song, Y., An, T., Wang, R., & Zhang, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-10422459/v1
Miller, M., Strojny, D., Sobański, D., Staszkiewicz, R., Gogol, P., Kucybała, W., & Grabarek, B. O. (2026) · Journal of Neuro-Oncology · doi:10.1007/s11060-026-05750-w
“TGF-β2 is linked to immunosuppression in CNS tumors, potentially via macrophage-exosome-mediated activation [ 12 ]; TGF-β3 may contribute to dural attachment and invasive - ness [8, 9 ].”
InfluentialSKI is critical to counter TGF-β signaling to promote T cell function and autoimmunity
Wang, J., Chen, Z., Li, H., Guo, Z., Wang, G., Zheng, J., & Wan, Y. Y. (2026) · Science Advances · doi:10.1126/sciadv.aeb7051
Amano, H., Komuro, A., Ota, K., Honda, M., Sakai, K., Nishio, K., Ueda, T., & Okada, H. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102752
Luo, R., Li, S., Wang, H., Zhang, Z., Li, L., & Shang, P. (2026) · Genes and Immunity · doi:10.1038/s41435-026-00407-0
The instructive scar – the dynamic role of extracellular matrix in biliary pathophysiology
Waddell, S. H., Brennan, E., & Boulter, L. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052835
“Transforming growth factor beta (TGF β ) is a superfamily of receptors and ligands that regulate a myriad of biological processes across development and disease (Derynck and Budi, 2019).”
Du, M., & Wang, L. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70293
“Because TGF‐beta family pathways are central to tissue remodeling and skeletal signaling, future bone‐specific work should clarify how phosphorylation‐linked chromatin changes interact with osteogenic and resorptive pathways [57].”
Zhang, J., Feng, J., Song, J., & Bi, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1919772
“Activated SMAD2/3 forms a complex with SMAD4 and translocates to the nucleus, where it regulates target-gene transcription in cooperation with other transcriptional regulators (Hata and Chen, 2016; Derynck and Budi, 2019).”
Wang, H., Cui, J., Huang, C., Guo, W., Liu, T., Zhu, Y., Shao, S., Chen, K., He, J., & Bao, Q. (2026) · Advanced Science · doi:10.1002/advs.77379
“The constitutively active TGFR-2 then phosphorylates TGFR-1 within its juxtamembrane GS domain, inducing conformational changes that promote displacement of the inhibitory protein PPIase FKBP1A and enable docking and phosphorylation of receptor-activated SMAD2 and SMAD3 [ 38 ].”
Farooq, M. A., Atiyah, H. L., ahmed, A. H., & A-Rubaye, T. S. (2026) · PAIN JOINTS SPINE · doi:10.1922/pjs.16.4s.2025.684
“The human TGF-β family includes thirty-three genes that encode for homodimeric or heterodimeric secreted cytokines[14,15].”
Zhou, J., Guo, H., Zhu, T., Xian, L., Liu, B.-S., Zhang, N., Zhu, K.-C., & Zhang, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188061
“…subgroup possessed the characteristic GS region together with intracellular serine/threonine kinase domains, whereas ACVR2 subgroup members contained conserved receptor kinase-related domains, supporting their potential involvement in ligand recognition and downstream signal transduction [20–22].”
Sukocheva, O. A., Harding, D., Ow, T., & Tse, E. (2026) · Biomedicines · doi:10.3390/biomedicines14092082
“A member of the transforming growth factor-β (TGF-β ) superfamily, myostatin is a well-established negative regulator of skeletal muscle growth [73,74].”
ATF3: Friend or foe in cellular stress and repair? A context-dependent stress rheostat framework
Huang, R., Li, R., Saw, P. E., & Zhou, M. (2026) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2026.151576
Zhang, Y., Mo, Y., Zhang, Y., Yuan, J., & Zhang, Q. (2026) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6c00144
Phytochemicals modulating TGF-β signaling in radiation-induced fibrosis
Goleij, P., Mirzaei, M., Babamohamadi, M., Sadreddini, S., Abolfazli, S., Tabari, M. A. K., Movafagh, A., Aschner, M., & Khan, H. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12867-8
“In mammals, there are three isoforms (TGF-β1, TGF-β2, and TGF-β3), which are generated as precursor proteins composed of an N-terminal signal peptide, a latency-associated prosegment (LAP), and a C-terminal mature polypeptide [14, 15].”
Vikas, B., Sweety, V. K., Edison, L. K., & Anil, S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1018053
Wu, Y., Li, S., Zhang, X., Xu, Q., Chen, B., Yang, W., Liu, M., Li, J., He, X., Li, J., et al. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05953-y
Wu, M., Wang, X., Zhang, H., Huiliang, X. U. E., Xu, J., Fan, C., Lei, C. H. E. N., & Laixiang, X. U. (2026) · Theriogenology · doi:10.1016/j.theriogenology.2026.118227
Liu, Z.-H., Gu, Y., Fan, H., Huang, M., Li, D., Guo, W., He, Y., Zhang, S., & Du, Z. (2026) · PLoS ONE · doi:10.1371/journal.pone.0359405
“Aberrant or sustained activation of this pathway is a recognized contributor to malignant progression [24], partly by suppressing pro-apoptotic and cell-cycle-inhibitory programs and activating proliferation-associated genes [25].”
AlRamadneh, T. N., Rizaev, J., Kadhim, A. A., Jamuna, K. V., Maharana, L., Bainsal, N., Singhal, D., & Polatova, D. S. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101493
Asymmetric crosstalk between the BMP and TGF-β pathways resolves signaling ambiguity
Auth, J. M., Eizenberg-Magar, I., Dekel, O. E., Zachar, O., Shmueli, M. D., Zigdon, I., Shoham, A., Mindel, V., Olender, T., Berrebi, M. A., et al. (2026) · Cell Systems · doi:10.1016/j.cels.2026.101757
Tang, L., Qiao, W., Wang, S., Wang, Z., Zhang, S., Liu, L., & Zhu, W. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1963705
DCAF6 reprograms TGF-β responses through TRIM33 destruction
Luo, H., Yuan, B., Liu, J., Yao, Z., Hong, H., Lin, D., Zhang, S., Qian, J., Li, J., Cao, J., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2602333123
Metadata
- Authors
- Derynck, R., & Budi, E. H.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Derynck, Rik
- Venue
- Science Signaling
- Published
- 2019-02-26
- Volume
- 12
- Issue
- 570
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC6800142
- OpenAlex
- W2917714624
- Cited by
- 785
- References
- 347
- Citations by year
- 2026: 83 · 2025: 85 · 2024: 129 · 2023: 118 · 2022: 102 · 2021: 152 · 2020: 77 · 2019: 35
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (RO1-CA63101, RO1-CA136690)
- JDRF (3-APF-2017-392-A-N)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Smad proteins, TGF-beta receptor, dual-specificity kinase, signaling crosstalk, non-Smad signaling, cancer, fibrosis, developmental anomalies
- MeSH terms
- Animals, Cell Differentiation, Gene Expression Regulation, Humans, Ligands, Neoplasms, Protein Binding, Signal Transduction, Transforming Growth Factor beta, Receptors, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review